Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature

The treatment of pediatric patients with refractory or relapsed anaplastic large cell lymphoma (ALCL) is still a major challenge. In addition to conventional chemotherapy and stem cell transplantation, new therapeutic options such as anti-CD30 drugs and anaplastic lymphoma kinase (ALK) inhibitors ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Caddeo, Giulia, Tecchio, Cristina, Chinello, Matteo, Balter, Rita, Zaccaron, Ada, Vitale, Virginia, Pezzella, Vincenza, Bonetti, Elisa, Pillon, Marta, Carraro, Elisa, Mussolin, Lara, Cesaro, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241741/
https://www.ncbi.nlm.nih.gov/pubmed/37072555
http://dx.doi.org/10.1007/s44228-023-00038-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241741/
https://www.ncbi.nlm.nih.gov/pubmed/37072555
http://dx.doi.org/10.1007/s44228-023-00038-6

Ejemplares similares